Cargando…
Radiotherapy–immunotherapy combinations – perspectives and challenges
Ionizing radiation has historically been used to treat cancer by killing tumour cells, in particular by inducing DNA damage. This view of radiotherapy (RT) as a simple cytotoxic agent has dramatically changed in recent years, and it is now widely accepted that RT can deeply reshape the tumour enviro...
Autores principales: | Mondini, Michele, Levy, Antonin, Meziani, Lydia, Milliat, Fabien, Deutsch, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332212/ https://www.ncbi.nlm.nih.gov/pubmed/32112478 http://dx.doi.org/10.1002/1878-0261.12658 |
Ejemplares similares
-
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy
por: Hamon, Pauline, et al.
Publicado: (2022) -
Macrophages in radiation injury: a new therapeutic target
por: Meziani, Lydia, et al.
Publicado: (2018) -
Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models
por: Tran Chau, Vanessa, et al.
Publicado: (2020) -
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation
por: Meziani, Lydia, et al.
Publicado: (2023) -
KRAS(G12C) inhibition using MRTX1257: a novel radio-sensitizing partner
por: Laurent, Pierre-Antoine, et al.
Publicado: (2023)